# DLX1

## Overview
DLX1 is a gene that encodes the protein distal-less homeobox 1, a transcription factor belonging to the homeobox family. This protein plays a pivotal role in the regulation of gene expression during embryonic development, particularly influencing the morphogenesis of craniofacial structures, the forebrain, and sensory organs. As a transcription factor, distal-less homeobox 1 is involved in the differentiation of various cell types, including neurons and hematopoietic cells, by interacting with other proteins and DNA elements to modulate transcriptional activity. Its function is critical in both developmental and pathological contexts, with implications in neurodevelopmental disorders and certain cancers (Chan2016DLX1; Zerucha2000A; Tan2021DLX).

## Function
DLX1 is a transcription factor that plays a significant role in embryonic and postnatal development, particularly in the morphogenesis of craniofacial structures, branchial arches, forebrain, and sensory organs. It is crucial for the formation of the retina, where its absence can lead to apoptosis of retinal ganglion cells and a diminished ganglion cell layer, resulting in non-viability in newborn mice (Tan2021DLX). DLX1 is expressed in the developing thymus and is involved in the regulation of hematopoiesis by interacting with SMAD4, affecting the transactivation of TGF-β family members (Tan2021DLX).

In the bone marrow of adult mice, DLX1 is transiently expressed in immature NK cells, and its persistent expression can lead to functionally immature NK cells and stall the differentiation of T-cells and B-cells, partially through the aryl hydrocarbon receptor (AhR) (Tan2021DLX). DLX1, along with DLX2, is involved in the differentiation of late-born striatal neurons and can bind to the intergenic enhancer of DLX5/6, indicating a regulatory role in gene expression (Tan2021DLX). These functions highlight DLX1's involvement in critical developmental processes and its regulatory influence on other genes.

## Clinical Significance
Mutations and alterations in the expression of the DLX1 gene have been implicated in several clinical conditions. DLX1, along with DLX2, plays a crucial role in the development of the striatum and the differentiation of neurons in the forebrain. Mutations in these genes can disrupt normal neuronal migration and differentiation, leading to significant developmental abnormalities in the brain, such as those observed in the striatal subventricular zone (SVZ) and olfactory bulb (Anderson1997Mutations).

DLX1 has also been associated with autism spectrum disorders (ASD). Studies have identified significant associations between certain single nucleotide polymorphisms (SNPs) in the DLX1 gene and ASD, particularly in families with multiple affected individuals. These findings suggest that DLX1 may contribute to ASD susceptibility through its role in the development of GABAergic cortical interneurons, which are essential for maintaining the balance between excitation and inhibition in the brain (Liu2008The).

In addition to its role in neurodevelopmental disorders, aberrant expression of DLX1 has been linked to hematological malignancies, such as leukemias and lymphomas. DLX1 is involved in hematopoietic differentiation and interacts with signaling pathways that are often dysregulated in these cancers (Tan2021DLX).

## Interactions
DLX1, a transcription factor, is known to interact with several proteins and nucleic acids, playing a significant role in various cellular processes. In the context of ovarian cancer, DLX1 interacts with SMAD4, a key component of the TGF-β signaling pathway. This interaction occurs in the nucleus and is enhanced upon TGF-β1 stimulation, leading to the upregulation of TGF-β signaling targets such as PAI-1 and JUNB. The interaction between DLX1 and SMAD4 is crucial for modulating TGF-β/SMAD4 signaling pathways, which are involved in cancer cell proliferation, migration, and invasion (Chan2016DLX1).

DLX1 also forms heterodimeric complexes with Msx homeoproteins, resulting in functional antagonism. This dimerization inhibits the DNA binding and transcriptional activities of both Msx and Dlx proteins, suggesting that monomeric forms are active while heterodimeric forms are inactive. These interactions highlight the importance of protein-protein interactions in regulating homeoprotein functions (Zhang1997Heterodimerization).

In developmental contexts, DLX1, along with DLX2, binds to specific enhancer elements within the dlx5/dlx6 intergenic region, activating transcription. This interaction is essential for the expression of Dlx5 and Dlx6, particularly in the embryonic forebrain (Zerucha2000A).


## References


[1. (Liu2008The) Xudong Liu, Natalia Novosedlik, Ami Wang, Melissa L Hudson, Ira L Cohen, Albert E Chudley, Cynthia J Forster-Gibson, Suzanne M E Lewis, and Jeanette J A Holden. The dlx1and dlx2 genes and susceptibility to autism spectrum disorders. European Journal of Human Genetics, 17(2):228–235, August 2008. URL: http://dx.doi.org/10.1038/ejhg.2008.148, doi:10.1038/ejhg.2008.148. This article has 64 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/ejhg.2008.148)

[2. (Zhang1997Heterodimerization) Hailan Zhang, Gezhi Hu, Hongyu Wang, Peter Sciavolino, Nancy Iler, Michael M. Shen, and Cory Abate-Shen. Heterodimerization of msx and dlx homeoproteins results in functional antagonism. Molecular and Cellular Biology, 17(5):2920–2932, May 1997. URL: http://dx.doi.org/10.1128/mcb.17.5.2920, doi:10.1128/mcb.17.5.2920. This article has 351 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.17.5.2920)

[3. (Zerucha2000A) Ted Zerucha, Thorsten Stühmer, Gary Hatch, Byung K. Park, Qiaoming Long, Guoying Yu, Adrianna Gambarotta, Joshua R. Schultz, John L. R. Rubenstein, and Marc Ekker. A highly conserved enhancer in thedlx5/dlx6intergenic region is the site of cross-regulatory interactions betweendlxgenes in the embryonic forebrain. The Journal of Neuroscience, 20(2):709–721, January 2000. URL: http://dx.doi.org/10.1523/JNEUROSCI.20-02-00709.2000, doi:10.1523/jneurosci.20-02-00709.2000. This article has 409 citations.](https://doi.org/10.1523/JNEUROSCI.20-02-00709.2000)

[4. (Tan2021DLX) Yinfei Tan and Joseph R. Testa. Dlx genes: roles in development and cancer. Cancers, 13(12):3005, June 2021. URL: http://dx.doi.org/10.3390/cancers13123005, doi:10.3390/cancers13123005. This article has 31 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers13123005)

[5. (Anderson1997Mutations) Stewart A Anderson, Mengsheng Qiu, Alessandro Bulfone, David D Eisenstat, Juanito Meneses, Roger Pedersen, and John L.R Rubenstein. Mutations of the homeobox genes dlx-1 and dlx-2 disrupt the striatal subventricular zone and differentiation of late born striatal neurons. Neuron, 19(1):27–37, July 1997. URL: http://dx.doi.org/10.1016/s0896-6273(00)80345-1, doi:10.1016/s0896-6273(00)80345-1. This article has 424 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/s0896-6273(00)80345-1)

[6. (Chan2016DLX1) D W Chan, W W Y Hui, J J Wang, M M H Yung, L M N Hui, Y Qin, R R Liang, T H Y Leung, D Xu, K K L Chan, K-M Yao, B K Tsang, and H Y S Ngan. Dlx1 acts as a crucial target of foxm1 to promote ovarian cancer aggressiveness by enhancing tgf-β/smad4 signaling. Oncogene, 36(10):1404–1416, September 2016. URL: http://dx.doi.org/10.1038/onc.2016.307, doi:10.1038/onc.2016.307. This article has 40 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/onc.2016.307)